On Monday, Biodesix Inc (NASDAQ: BDSX) opened higher 5.78% from the last session, before settling in for the closing price of $0.36. Price fluctuations for BDSX have ranged from $0.17 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 69.26% over the past five years. Company’s average yearly earnings per share was noted 26.47% at the time writing. With a float of $69.36 million, this company’s outstanding shares have now reached $146.44 million.
Let’s look at the performance matrix of the company that is accounted for 273 employees. In terms of profitability, gross margin is 78.38%, operating margin of -43.71%, and the pretax margin is -54.28%.
Biodesix Inc (BDSX) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Biodesix Inc is 52.68%, while institutional ownership is 34.20%. The most recent insider transaction that took place on May 16 ’25, was worth 1,070,000. In this transaction Director of this company bought 4,000,000 shares at a rate of $0.27, taking the stock ownership to the 20,194,935 shares. Before that another transaction happened on May 19 ’25, when Company’s Director bought 723,239 for $0.34, making the entire transaction worth $246,624. This insider now owns 20,918,174 shares in total.
Biodesix Inc (BDSX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 26.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.97% during the next five years compared to 69.26% growth over the previous five years of trading.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Check out the current performance indicators for Biodesix Inc (BDSX). In the past quarter, the stock posted a quick ratio of 2.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
Biodesix Inc (NASDAQ: BDSX) saw its 5-day average volume 0.79 million, a negative change from its year-to-date volume of 4.14 million. As of the previous 9 days, the stock’s Stochastic %D was 30.82%.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 30.11%, which indicates a significant decrease from 56.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0399 in the past 14 days, which was lower than the 0.0518 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3187, while its 200-day Moving Average is $0.8401.
